- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | BPH GLOBAL LTD: R&D Program Focused on Gold and Silver Recovery from Seaweed | - | ASX | ||
| BPH GLOBAL Aktie jetzt für 0€ handeln | |||||
| 30.12.25 | BPH GLOBAL LTD: December Trading Results Seasonal Impact & Growth Focus | - | ASX | ||
| 24.12.25 | BPH GLOBAL LTD: Notification of cessation of securities - BP8 | - | ASX | ||
| 16.12.25 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 11.12.25 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 08.12.25 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 04.12.25 | BPH GLOBAL LTD: Change of Director's Interest Notices x 4 | - | ASX | ||
| 04.12.25 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 02.12.25 | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 02.12.25 | BPH GLOBAL LTD: Notification regarding unquoted securities - BP8 | - | ASX | ||
| 01.12.25 | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 01.12.25 | BPH GLOBAL LTD: Becoming a substantial holder | - | ASX | ||
| 27.11.25 | BPH GLOBAL LTD: Section 708A Notice | - | ASX | ||
| 27.11.25 | BPH GLOBAL LTD: Application for quotation of securities - BP8 | - | ASX | ||
| 16.11.25 | BPH GLOBAL LTD: Record Growth in Seaweed Sales | - | ASX | ||
| 14.11.25 | BPH GLOBAL LTD: Results of Meeting | - | ASX | ||
| 11.11.25 | BPH GLOBAL LTD: First-Mover Advantage in Seaweed Male Vitality Formulation | - | ASX | ||
| 06.11.25 | BPH GLOBAL LTD: BPH Global Strengthens Advisory Board | - | ASX | ||
| 05.11.25 | BPH Global Enters Exclusive Agreement for Ginseng Formulation | 1 | Finance News Network | ||
| 04.11.25 | BPH GLOBAL LTD: Exclusive Agreement to Develop Male Performance Product | - | ASX |
1 2 3 4 Weiter >>
64 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EPIGENOMICS | 0,900 | 0,00 % | PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG | DJ PTA-AFR: Epigenomics AG: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß §§ 114-117 WpHG
Vorabbekanntmachung Finanzberichte gemäß ---- 114-117 WpHG
Epigenomics... ► Artikel lesen | |
| CO.DON | 0,021 | -18,00 % | EQS-PVR: CO.DON AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: CO.DON AG
CO.DON AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
07.01.2026 / 12:38 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| SIRONA BIOCHEM | 0,037 | -100,00 % | Sirona Biochem Corp.: Sirona Biochem Update to Shareholders on Financial Status and Operations | VANCOUVER, British Columbia, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) ("Sirona") wishes to provide shareholders with a critical update on the company's financial... ► Artikel lesen | |
| NUREXONE BIOLOGIC | 0,400 | 0,00 % | NurExone schafft Grundlage für First-in-Human-Perspektive mit ExoPTEN | ||
| REPLENISH NUTRIENTS | 0,070 | -4,36 % | Replenish Nutrients 2025 Year-in-Review: Record Growth and Licensing Deals Drive Regenerative Fertilizer Momentum | ||
| NEOVACS | 0,002 | -67,57 % | XFRA NEW INSTRUMENTS AVAILABLE ON 18.07.2025 | The following instruments on XETRA do have their first trading 18.07.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 18.07.2025
Aktien
1 KYG7388C1033 Qunabox Group Ltd.
2... ► Artikel lesen | |
| GENETIC TECHNOLOGIES | 0,034 | -100,00 % | GENETIC TECHNOLOGIES LIMITED: Final Director's Interest Notice - A Hartman | ||
| TRIVARX | - | - | TRIVARX LTD: Final Director's Interest Notice - John Mathias | ||
| RECCE PHARMACEUTICALS | 0,418 | +7,73 % | Recce Pharmaceuticals - Up to A$85m of overseas R&D funding secured | Recce Pharmaceuticals recently reported that the Australian government has agreed to provide it with up to A$85m in future cash rebates over the next three years to reimburse the company's upcoming... ► Artikel lesen | |
| CRISM THERAPEUTICS | - | - | CRISM Therapeutics - Results of Shareholder Analysis | ||
| THX PHARMA | 2,080 | -4,15 % | THERANEXUS: THX Pharma announces the publication of its letter to shareholders | Lyon, France - January 8, 2025, 6:00 PM CET - THX Pharma (Theranexus), an innovative biopharmaceutical company in the treatment of rare neurological diseases, today announces the publication of... ► Artikel lesen | |
| PYC THERAPEUTICS | - | - | PYC THERAPEUTICS LIMITED: Offer to Issue Director Options and Appendix 3Y | ||
| PATRYS | - | - | PATRYS LIMITED: Letter to Shareholders - General Meeting | ||
| MOONLAKE IMMUNOTHERAPEUTICS | 18,610 | +29,69 % | MoonLake Immunotherapeutics AG: MoonLake Immunotherapeutics Announces Positive Outcome from Type B Meeting with U.S. FDA and Announces Investor Day | MoonLake requested a Type B meeting with the U.S. Food and Drug Administration (FDA) to obtain regulatory clarity and discuss the clinical evidence strategy for submission of a Biologic License Application... ► Artikel lesen | |
| CG ONCOLOGY | 54,30 | +29,49 % | CG Oncology Inc.: CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC | - PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial... ► Artikel lesen |
Das Unternehmen BPH GLOBAL LTD kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BPH GLOBAL LTD finden Sie auf Wallstreet Online.